Top Markets
Coin of the day
Abpro Corporation Abpro Corporation

Abpro Corporation

ABP
Pozycja w akcjach #39900
Abpro Holdings, Inc. is a biotechnology firm dedicated to creating... Abpro Holdings, Inc. is a biotechnology firm dedicated to creating antibody-based treatments for patients suffering from conditions in immuno-oncology, ophthalmology, and autoimmunity. A key element of their strategy is the proprietary DiversImmune platform, which aims to resolve a significant hurdle in the antibody therapeutics sector. Their primary investigational drug candidates include ABP-100, designed to target breast, gastric, and colorectal cancers, and ABP-201, intended for the treatment of vascular diseases affecting the eye. The company has established strategic alliances with Abpro Bio Co. Ltd and NJCTTQ. Originally known as Abpro Corporation, the company officially changed its name to Abpro Holdings, Inc. in November 2024. Incorporated in 2004, Abpro Holdings, Inc. operates from its headquarters in Woburn, Massachusetts.
Cena akcji
$0.158
Ostatnia synchronizacja: 2026-04-06
Kapitalizacja rynkowa
$302.92K
Zmiana (1 dzień)
16.18%
Zmiana (1 rok)
-97.91%
Kraj
US
Handel Abpro Corporation (ABP)

Kategoria

Historia stopy dywidendy dla Abpro Corporation (ABP)
Stopa dywidendy (TTM) dla Abpro Corporation (symbol akcji: ABP) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Abpro Corporation (ABP) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji